Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 1, 2006

Published online before print February 3, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0605350v1
79/4/779    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGettrick, H. M.
Right arrow Articles by Nash, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGettrick, H. M.
Right arrow Articles by Nash, G. B.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0605350


Received for publication June 29, 2005.
Revised November 2, 2005.
Accepted for publication November 29, 2005.


Article

Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium

Helen M. McGettrick *{dagger}, Janet M. Lord {dagger}, Ke-Qing Wang {dagger}, G. Ed Rainger *{dagger}, Christopher D. Buckley *{dagger}, and Gerard B. Nash *{dagger}@

*Centre for Cardiovascular Sciences and {dagger}MRC Centre for Immune Regulation, The Medical School, The University of Birmingham, United Kingdom

@ To whom correspondence should be addressed. E-mail: g.nash{at}bham.ac.uk.


   Abstract

We examined the fate of neutrophils following transmigration through an endothelial monolayer cultured on "Transwell" membrane filters. Treatment of human umbilical vein endothelial cells (HUVEC) with increasing doses of tumor necrosis factor-{alpha} increased the efficiency of transmigration and markedly reduced apoptosis among the transmigrated neutrophils in a dose-dependent manner. Apoptosis was also inhibited after transmigration of neutrophils through HUVEC stimulated with interleukin (IL)-1{beta} but not so effectively after chemotaxis through unstimulated HUVEC driven by IL-8 added below the filter. Inhibition of {beta}2-integrin binding after transmigration or coating the lower chamber with a nonadhesive polymer (polyhydroxyl-ethyl-methacrylate) abrogated neutrophil survival. Although integrin engagement during migration itself was not essential to inhibit apoptosis, activation of neutrophils through CXC chemokine receptors was necessary. Quite brief exposure to the HUVEC (30-120 min) was effective in reducing subsequent apoptosis, although if coincubation with the HUVEC were prolonged, neutrophil apoptosis was reduced further. Neutralization of granulocyte macrophage-colony stimulating factor inhibited this additional effect. Thus, a complex interplay between migration- and activation-dependent signals and adhesive interaction in tissue may combine to effectively prolong the survival of neutrophils recruited during inflammation.

Key Words: apoptosis • leukocyte trafficking • endothelial cells • adhesion molecules




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Haudek, J. Trial, Y. Xia, D. Gupta, D. Pilling, and M. L. Entman
Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells
PNAS, July 22, 2008; 105(29): 10179 - 10184.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. T. Mierke, D. P. Zitterbart, P. Kollmannsberger, C. Raupach, U. Schlotzer-Schrehardt, T. W. Goecke, J. Behrens, and B. Fabry
Breakdown of the Endothelial Barrier Function in Tumor Cell Transmigration
Biophys. J., April 1, 2008; 94(7): 2832 - 2846.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Dever, C. M. Spickett, S. Kennedy, C. Rush, G. Tennant, A. Monopoli, and C. L. Wainwright
The Nitric Oxide-Donating Pravastatin Derivative, NCX 6550 [(1S-[1{alpha}(betaS*, {delta}S*), 2{alpha}, 6{alpha}, 8beta-(R*), 8a{alpha}]]-1,2,6,7,8,8a-Hexahydro-beta, {delta}, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic Acid 4-(Nitrooxy)butyl Ester)], Reduces Splenocyte Adhesion and Reactive Oxygen Species Generation in Normal and Atherosclerotic Mice
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 419 - 426.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.